Henry Schein | HSIC - Cost Of Sales

Stock Price
80.97
Daily Change
-0.50 -0.61%
Monthly
7.85%
Yearly
12.19%
Q1 Forecast
77.10

Henry Schein reported $2.44B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Agilent USD 852M 19M Dec/2025
Align Technology USD 363.97M 7.48M Dec/2025
Bruker USD 528M 46.9M Dec/2025
Cardinal Health USD 63.36B 1.57B Dec/2025
Charles River Laboratories USD 722.27M 28.81M Dec/2025
Cigna USD 63.37B 1.93B Sep/2025
Concord Medical Services Hldg CNY 321.94M 69.56M Jun/2023
Cooper Companies USD 464.2M 45.9M Sep/2025
CVS Health USD 92.13B 3.06B Dec/2025
Danaher USD 2.87B 342M Dec/2025
Dentsply International USD 518M 55M Dec/2025
Encompass Health USD 150.9M 3.9M Dec/2025
Henry Schein USD 2.44B 62M Dec/2025
Idexx Laboratories USD 432.46M 10.58M Dec/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Laboratory Of America USD 2.6B 56.8M Dec/2025
McKesson USD 102.47B 2.86B Dec/2025
Mettler Toledo International USD 473.97M 33.71M Dec/2025
Owens Minor USD 2.11B 10.27M Mar/2025
Quest Diagnostics USD 1.93B 27M Dec/2025
Revvity USD 350.4M 26.05M Dec/2025
Stryker USD 2.69B 373M Dec/2025
Tenet Healthcare USD 1.24B 1.89B Dec/2025
Thermo Fisher Scientific USD 7.58B 674M Dec/2025
Universal Health Services USD 2.49B 52.74M Sep/2025
Veradigm USD 68.49M 2.93M Sep/2022
Waters USD 374.94M 47.13M Dec/2025
Zimmer Biomet Holdings USD 970.1M 234.3M Dec/2025
Zoetis USD 743M 60M Dec/2025